{"id":6757,"date":"2015-09-04T10:12:09","date_gmt":"2015-09-04T10:12:09","guid":{"rendered":"\/?p=6757"},"modified":"2015-09-04T10:39:30","modified_gmt":"2015-09-04T10:39:30","slug":"bionovelus-inc-otcmktsonov-crashes-horribly","status":"publish","type":"post","link":"\/articles\/bionovelus-inc-otcmktsonov-crashes-horribly\/","title":{"rendered":"BioNovelus Inc. (OTCMKTS:ONOV) Crashes Horribly"},"content":{"rendered":"\n

Yesterday BioNovelus Inc. (OTCMKTS:ONOV<\/a>)’s pump finally went sour, taking the ticker all the way down to the $0.08 mark over the course of a single session. <\/p>\n

As investors well know, it is not uncommon for tickers that have been on the receiving end of a paid pump campaign to lose all their market cap gains and then some when the whole thing goes bad. This is why it was not surprising to see ONOV<\/a> <\/strong>crash 52.94% in yesterday’s session, and why it wouldn’t really be surprising to see the ticker fall further down the charts in today’s session as well.<\/p>\n

Even before the crash started, there could have been little doubt that ONOV<\/a> <\/strong>was just your average OTC Markets pump job. The company certainly fulfills all the criteria to be classified as such – its management was spewing loud, boastful and unrealistic statements left and right. Said statements were, of course, completely unsubstantiated, because its financials looked positively dismal:<\/p>\n